SCHEMBL22163201

SCHEMBL22163201

Nc1cccc(N2CC[C@@H](O)C2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.48
▸ GRIN3B O60391 1/20 0.48
▸ GRIN1 Q05586 1/20 0.48
▸ GRIN2A Q12879 1/20 0.48
▸ GRIN2B Q13224 1/20 0.48
▸ GRIN2C Q14957 1/20 0.48
▸ GRIN3A Q8TCU5 1/20 0.48
▸ SMPD3 Q9NY59 3/20 0.45
▸ PDE10A Q9Y233 4/20 0.44
▸ HTR3E A5X5Y0 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HTR3B O95264 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ HTR3A P46098 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HTR3D Q70Z44 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15652231 1.00 GRIN2D (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22163217 0.91 SMPD3 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29609676 0.91 SMPD3 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22122618 0.91 SMPD3 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22122617 0.91 SMPD3 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL23104546 0.90 SMPD3 (0.51) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL20689452 0.86 GRIN2B (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31118805 0.82 HTR3E (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22163207 0.81 SMPD3 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14902336 0.81 SMPD3 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002311-A1 KIF18A INHIBITORS AMGEN INC. (US) 2022-01-06 — — US disclosed
WO-2020132653-A1 HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS AMGEN INC. (US) 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002311-A1 KIF18A INHIBITORS KIF18A, KIF18B, KIF15 GRIN2D 4395/4885GRIN3B 3817/4885GRIN1 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback